Predictions
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Theranexus
Start price
Target price
Perf. (%)
€3.18
04.02.22
04.02.22
€36.00
04.02.23
04.02.23
-41.98%
05.02.23
05.02.23
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€3.51
01.02.22
01.02.22
€4.15
01.02.23
01.02.23
-7.69%
10.02.22
10.02.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.90
23.01.22
23.01.22
-
23.01.23
23.01.23
-5.47%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€4.12
10.01.22
10.01.22
-
10.01.23
10.01.23
-14.85%
01.02.22
01.02.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€19.03
04.01.22
04.01.22
-
04.01.23
04.01.23
-7.46%
07.01.22
07.01.22
Risky Investment
Quantum Genomics S.A.
Start price
Target price
Perf. (%)
€4.32
31.12.21
31.12.21
€5.00
31.12.22
31.12.22
-97.78%
01.01.23
01.01.23
Could be worthwhile Investment >10% per year
Eurobio scientific
Start price
Target price
Perf. (%)
€28.54
26.12.21
26.12.21
-
26.12.22
26.12.22
-32.45%
14.03.22
14.03.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€24.64
16.12.21
16.12.21
€33.00
31.12.23
31.12.23
-67.02%
07.09.22
07.09.22
Could be very worthwhile Investment >20% year
Sanofi S.A.
Start price
Target price
Perf. (%)
€85.57
14.12.21
14.12.21
€124.00
14.12.22
14.12.22
5.18%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
12.12.21
12.12.21
-
12.12.22
12.12.22
8.73%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
11.12.21
11.12.21
€30.00
11.12.22
11.12.22
8.73%
25.12.21
25.12.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Oncodesign S.A.
Start price
Target price
Perf. (%)
€8.61
08.12.21
08.12.21
€10.00
08.12.22
08.12.22
65.85%
09.12.22
09.12.22
Could be worthwhile Investment >10% per year